Comirnaty JN.1 6 months to <5 years (yellow cap) formulation

Registered for use in people aged 6 months - <5 years 

COVID-19 vaccine containing nucleoside-modified mRNA encoding the spike glycoproteins of SARS-CoV-2 JN.1 strain.  

Multi dose vial without preservative containing 0.3 mL of concentrated suspension for injection vaccine. Requires dilution with 0.9% sodium chloride. Each vial contains 3 doses (0.3mL per dose after dilution) in 0.48mL.

Each 0.3 mL dose contains: 

• 3 µg mRNA encoding the SARS-CoV-2 JN.1 spike glycoprotein  
• ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315) 
• 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159)
• Distearoylphosphatidylcholine (DSPC)  
• Cholesterol  
• Trometamol  
• Trometamol hydrochloride  
• Sucrose  
• Water for injections 

For Product Information and Consumer Medicine Information about Comirnaty JN.1 visit the Therapeutic Goods Administration website.